PTR Shares PTR Minerals Ltd
ASX · ASXLast in our picks 2026-10-05 — not in the current list; analysis below is from that screen
Not a biotech; excluded-style fallback only if searching broader healthcare themes.
Future value: $0.24 (+166.67%) · 6-12 months
Signal breakdown
- ▸Low liquidity and weak biotech relevance limit investability.
- ▾Below 50-day MA (-11.83%)
- ▾Near 52-week low (4.7% of range)
- ▸~167% upside to price target
Is PTR a buy right now?
Trend: PTR is trading below the 50-day average (-20.00%), RSI 20 — oversold territory, with a 3-month return of -1.23%.
Valuation & quality: PTR Minerals Ltd trades on price-to-book 1.31; fundamentals show net margin 0.0%, return on equity -16.0%, revenue growth 364.5% year on year.
Analyst consensus: 1 analysts have a mean 12-month price target of A$0.73 (+812.5% vs the last close; range A$0.73 – A$0.73), consensus rating “none”.
Our screen: ACCUMULATE (score 1) — Not a biotech; excluded-style fallback only if searching broader healthcare themes.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -52.40% | +0.00% | +10.00% | -18.20% | -11.10% | +37.50% | -18.20% | -11.10% |
Fundamentals
Analyst price target
Technical signals
About PTR Minerals Ltd
PTR Minerals Ltd, together with its subsidiaries, engages in the mineral exploration activities in Australia. It explores for gold, titanium, copper, iron-oxide, and rare earth mineral deposits.
Sector: Basic Materials · Industry: Other Precious Metals & Mining · Australia · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.